Sign in

CIK 0001346830

  • Non-accelerated filer
  • Smaller reporting company

Tvardi Therapeutics, Inc.

Sign in to watch
Ticker
TVRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 713-489-8654
Business address
3 SUGAR CREEK CTR. BLVD., STE 525, SUGAR LAND, TX, 77478
Former names
Cara Therapeutics, Inc., Cara Therapeutics Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-12-28 CHALMERS DEREK T President & CEO Sale −5,000 $16.00 $80K 942,671
2020-12-23 Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Grant or award +8,000 112,492
2020-12-23 Goncalves Joana Chief Medical Officer Grant or award +4,000 31,373
2020-12-23 Terrillion Scott Sec'y; Chief Compliance & G.C. Grant or award +6,000 44,382
2020-12-23 CHALMERS DEREK T President & CEO Grant or award +18,750 947,671
2020-12-21 Goncalves Joana Chief Medical Officer Sale −2,000 $15.00 $30K 27,373
2020-12-16 CHALMERS DEREK T President & CEO Sale −5,000 $14.95 $75K 928,921
2020-12-10 CHALMERS DEREK T President & CEO Sale −7,500 $15.29 $115K 933,921
2020-11-23 Goncalves Joana Chief Medical Officer Sale −2,000 $15.31 $31K 29,373
2020-11-19 Ives Jeffrey L. Director Sale −2,500 $15.75 $39K 10,700
2020-11-19 Posner Christopher Director Sale −2,000 $15.82 $32K 11,200
2020-11-19 Ives Jeffrey L. Director Grant or award +2,500 $15.75 $39K 10,700
2020-11-17 VOGELBAUM MARTIN Director Sale −6,000 $16.09 $97K 14,400
2020-11-17 CHALMERS DEREK T President & CEO Sale −11,799 $16.00 $189K 941,421
2020-11-10 Goncalves Joana Chief Medical Officer Sale −2,000 $15.00 $30K 31,373
2020-10-20 Goncalves Joana Chief Medical Officer Sale −2,000 $15.00 $30K 33,373
2020-10-01 Reilly Thomas Charles Chief Financial Officer Grant or award · Stock Option (Right to Buy) +175,000 175,000
2020-09-03 CHALMERS DEREK T President & CEO Sale −3,201 $16.00 $51K 953,220
2020-08-03 CHALMERS DEREK T President & CEO Sale −5,000 $16.42 $82K 956,421
2020-07-01 CHALMERS DEREK T President & CEO Sale −5,000 $17.11 $86K 961,421

Page 12 of 15 · 284 trades